17‐Beta Hydroxysteroid Dehydrogenase 13 Deficiency Does Not Protect Mice From Obesogenic Diet Injury-Reference-Cited by-同舟云学术

17‐Beta Hydroxysteroid Dehydrogenase 13 Deficiency Does Not Protect Mice From Obesogenic Diet Injury

Published:2021-03-16 Issue:5 Volume:73 Page:1701-1716
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Ma Yanling¹²,Brown Philip M.¹²,Lin Dennis D.¹²,Ma Jing³,Feng Dechun³,Belyaeva Olga V.⁴,Podszun Maren C.¹²,Roszik Jason⁵⁶,Allen Joselyn N.²,Umarova Regina²,Kleiner David E.⁷,Kedishvili Natalia Y.⁴,Gavrilova Oksana⁸,Gao Bin³,Rotman Yaron¹²^ORCID

Affiliation:

1. Liver & Energy Metabolism Section National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health Bethesda MD

2. Liver Diseases Branch National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health Bethesda MD

3. Laboratory of Liver Diseases National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health Bethesda MD

4. Department of Biochemistry and Molecular Genetics, Schools of Medicine and Dentistry University of Alabama–Birmingham Birmingham AL

5. Department of Melanoma Medical Oncology–Research, Division of Cancer Medicine The University of Texas MD Anderson Cancer Center Houston TX

6. Department of Genomic Medicine, Division of Cancer Medicine The University of Texas MD Anderson Cancer Center Houston TX

7. Laboratory of Pathology, Center for Cancer Research National Cancer Institute, National Institutes of Health Bethesda MD

8. Mouse Metabolism Core National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health Bethesda MD

Funder

National Institute on Alcohol Abuse and Alcoholism

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.31517

Reference47 articles.

1. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention

2. Heritability of Hepatic Fibrosis and Steatosis Based on a Prospective Twin Study

3. Heritability of Nonalcoholic Fatty Liver Disease

4. Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity

5. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Murine HSD17β13 does not control liver steatosis and modestly impacts fibrosis in a sex- and diet-specific manner;Journal of Lipid Research;2024-08

2. 17-Beta-Hydroxysteroid Dehydrogenase 13 Loss of Function Does Not Confer Protection to Nonalcoholic Fatty Liver Disease in Indian Population;Journal of Clinical and Experimental Hepatology;2024-07

3. Metabolomics reveals dysregulated all-trans retinoic acid and polyunsaturated fatty acid metabolism contribute to PXR-induced hepatic steatosis in mice;Toxicology Letters;2024-07

4. Divergent role of Mitochondrial Amidoxime Reducing Component 1 (MARC1) in human and mouse;PLOS Genetics;2024-03-04

5. Evaluation of antisense oligonucleotide therapy targeting Hsd17b13 in a fibrosis mice model;Journal of Lipid Research;2024-03